Table 4

Comparison in morbidity and thrombotic stroke rate as a consequence of anticoagulant treatment per 1000 patients treated (first audit versus ideal)

First audit Total Warfarin treated Aspirin treated Expected cerebral haemorrhage Expected GI haemorrhage Expected non-GI haemorrhage
“Ideal” morbidity100075113582430
Actual morbidity100034028141514
Difference in adverse events294916
  • GI, gastrointestinal.